Sanford Z, et al. - Researchers examined how preoperative body mass index (BMI) influence clinical and subjective quality of life outcomes following laparoscopic anti-reflux surgery (LARS). According to CDC definitions, 869 patients were subdivided into four BMI stratified categories: 213 normal (18.5 to < 25), 323 overweight (25.0 to < 30), 219 obese Class 1 (30 to < 35), and 114 a combination of obese Class 2 (35 to < 40) and Class 3 (≥ 40). Outcomes revealed that LARS had similar value in addressing pathological reflux manifestations and conveying quality of life benefits among the overweight, obese, and morbidly obese populations when compared to normal-weight cohorts in short-term follow-up, without added morbidity or mortality.